Follow
Clinical Trial Testing
Clinical Trials are medical research involving human subjects. Clinical Trials evaluate medical, surgical, or behavioral interventions to determine if a novel treatment is safe and effective. There are four phases of Clinical Trial testing used to test the new treatment, determine the most effective dosage, and ensure the adverse effects do not outweigh the medical benefits.
What's Popular in Clinical Trial Testing
-
MAR 04, 2024Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab ...Sponsored By: Single Use SupportFEB 27, 2024Drug Discovery & Development
The CD4+ T cells of Rheumatoid arthritis patients have increased expression and concentration of ALOX5, the newly discov ...Written By: Amielle MorenoFEB 19, 2024Cancer
Georgios Nikolaou Papanikolaou and Andromache Mavroyeni married in Athens on September 25, 1910. No, this is not t ...Written By: Katie KokolusFEB 13, 2024Cardiology
Exercise has unique benefits for mental health in addition to its physical benefits.Written By: Savannah LoganJAN 14, 2024Neuroscience
Alzheimer's disease poses a significant therapeutic challenge due to the restrictive nature of the blood-brain barri ...Written By: Greta Anne
MAR 04, 2024
Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab
...
Sponsored By:
Single Use Support
FEB 27, 2024
Drug Discovery & Development
The CD4+ T cells of Rheumatoid arthritis patients have increased expression and concentration of ALOX5, the newly discov
...
Written By:
Amielle Moreno
FEB 19, 2024
Cancer
Georgios Nikolaou Papanikolaou and Andromache Mavroyeni married in Athens on September 25, 1910. No, this is not t
...
Written By:
Katie Kokolus
FEB 13, 2024
Cardiology
Exercise has unique benefits for mental health in addition to its physical benefits.
Written By:
Savannah Logan
JAN 14, 2024
Neuroscience
Alzheimer's disease poses a significant therapeutic challenge due to the restrictive nature of the blood-brain barri
...
Written By:
Greta Anne
JAN 04, 2024
Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca
...
Written By:
Carmen Leitch
JAN 03, 2024
Neuroscience
Clinical trial investigating the efficacy of smartphone app-delivered behavioral therapy and at-home tDCS for major depr
...
Written By:
Amielle Moreno
DEC 21, 2023
Cancer
The Christmas season has again come upon us, and in less than a week, millions worldwide will celebrate the holiday.&nbs
...
Written By:
Katie Kokolus
DEC 14, 2023
Cancer
Anixa Biosciences, a publicly traded (Nasdaq: ANIX) biotechnology company based in San Jose, California, recently announ
...
Written By:
Katie Kokolus
-
JAN 18, 2024 | 10:00 AM
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV pr...NOV 30, 2023 | 12:00 PMC.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
NOV 14, 2023 | 6:00 AM
C.E. CREDITS
It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstra...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
JAN 18, 2024 | 10:00 AM
In 2020, American Cancer Society released an updated cervical cancer screening guideline calling for primary human papillomavirus (HPV) screening as the preferred strategy. Utility of HPV pr...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
NOV 14, 2023 | 6:00 AM
C.E. CREDITS
It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstra...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
-
JAN 23, 2024 | 7:00 AM PST
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...APR 18, 2024C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......SEP 13, 2023 | 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...JAN 31, 2023 | 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...NOV 09, 2022 | 5:30 AM PSTC.E. CREDITS
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
JAN 23, 2024
| 7:00 AM PST
More than 90% of therapeutic candidates fail to make it past phase III clinical trials, mainly due to the lack of adequate, advanced cell models to provide in-depth predictive insights that...
APR 18, 2024
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
SEP 13, 2023
| 10:00 AM PDT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
JAN 31, 2023
| 8:00 AM PST
Empowering Multiplexing Innovation Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology u...
NOV 09, 2022
| 5:30 AM PST
C.E. CREDITS
Labroots is pleased to host the 13th Annual Event in the Clinical Diagnostics and Research Virtual Event Series to be held on November 9th, 2022. Registration is open now....
OCT 19, 2022
| 5:30 AM PDT
Labroots announces the 2022 Coronavirus Virtual Event Series. A novel coronavirus emerged in China in 2019; it has since been dubbed COVID-19....
JUN 22, 2022
| 3:00 AM PDT
Please join us for Ion World 2022, a virtual conference that will provide an opportunity to hear from scientists around the world, on how they are advancing research in a broad range of appl...
MAR 23, 2022
| 5:30 AM PDT
Labroots announces the 5th Annual 2021 Cannabis Sciences Virtual Event. Labroots will host the event on March 23, 2022, registration is now open....
FEB 23, 2022
| 5:30 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 5th annual event in the Drug Discovery & Development Virtual Event Series....